Literature DB >> 10985215

Proportional means regression for censored medical costs.

D Y Lin1.   

Abstract

The semiparametric proportional means model specifies that the mean function for the cumulative medical cost over time conditional on a set of covariates is equal to an arbitrary baseline mean function multiplied by an exponential regression function. We demonstrate how to estimate the vector-valued regression parameter using possibly censored lifetime costs. The estimator is consistent and asymptotically normal with an easily estimable covariance matrix. Simulation studies show that the proposed methodology is appropriate for practical use. An application to AIDS is provided.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10985215     DOI: 10.1111/j.0006-341x.2000.00775.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  12 in total

1.  Current Methods for Recurrent Events Data with Dependent Termination: A Bayesian Perspective.

Authors:  Debajyoti Sinha; Tapabrata Maiti; Joseph G Ibrahim; Bichun Ouyang
Journal:  J Am Stat Assoc       Date:  2008-06-01       Impact factor: 5.033

2.  Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysis.

Authors:  V F Fragoulakis; A G Pallis; D K Kaitelidou; N M Maniadakis; V G Georgoulias
Journal:  Lung Cancer (Auckl)       Date:  2012-07-16

3.  Semiparametric modeling and estimation of the terminal behavior of recurrent marker processes before failure events.

Authors:  Kwun Chuen Gary Chan; Mei-Cheng Wang
Journal:  J Am Stat Assoc       Date:  2017-05-03       Impact factor: 5.033

4.  BACKWARD ESTIMATION OF STOCHASTIC PROCESSES WITH FAILURE EVENTS AS TIME ORIGINS.

Authors:  Kwun Chuen Gary Chan; Mei-Cheng Wang
Journal:  Ann Appl Stat       Date:  2010-09-01       Impact factor: 2.083

5.  Nonparametric inference for the joint distribution of recurrent marked variables and recurrent survival time.

Authors:  Laura M Yee; Kwun Chuen Gary Chan
Journal:  Lifetime Data Anal       Date:  2015-09-30       Impact factor: 1.588

6.  Randomized trial of 2 dosages of prophylactic granulocyte-colony-stimulating factor after induction chemotherapy in pediatric acute myeloid leukemia.

Authors:  Hiroto Inaba; Xueyuan Cao; Stanley Pounds; Ching-Hon Pui; Jeffrey E Rubnitz; Raul C Ribeiro; Bassem I Razzouk
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

7.  A flexible model for the mean and variance functions, with application to medical cost data.

Authors:  Jinsong Chen; Lei Liu; Daowen Zhang; Ya-Chen T Shih
Journal:  Stat Med       Date:  2013-05-13       Impact factor: 2.373

8.  Survival and lifetime costs associated with first-line bevacizumab use in older patients with metastatic colorectal cancer.

Authors:  Veena Shankaran; David Mummy; Lisel Koepl; Aasthaa Bansal; Dana K Mirick; Elaine Yu; Rob Morlock; Sarika Ogale; Scott D Ramsey
Journal:  Oncologist       Date:  2014-08-01

9.  Longitudinal associations between types of childhood trauma and suicidal behavior among substance users: a cohort study.

Authors:  Brandon D L Marshall; Sandro Galea; Evan Wood; Thomas Kerr
Journal:  Am J Public Health       Date:  2013-07-18       Impact factor: 9.308

Review 10.  Considerations for observational research using large data sets in radiation oncology.

Authors:  Reshma Jagsi; Justin E Bekelman; Aileen Chen; Ronald C Chen; Karen Hoffman; Ya-Chen Tina Shih; Benjamin D Smith; James B Yu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-09-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.